[go: up one dir, main page]

TW200719891A - Film coated product - Google Patents

Film coated product

Info

Publication number
TW200719891A
TW200719891A TW095117776A TW95117776A TW200719891A TW 200719891 A TW200719891 A TW 200719891A TW 095117776 A TW095117776 A TW 095117776A TW 95117776 A TW95117776 A TW 95117776A TW 200719891 A TW200719891 A TW 200719891A
Authority
TW
Taiwan
Prior art keywords
film coated
coated product
film coat
preparation
carboxymethi
Prior art date
Application number
TW095117776A
Other languages
Chinese (zh)
Other versions
TWI367755B (en
Inventor
Takeshi Hamaura
Susumu Hasegawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200719891A publication Critical patent/TW200719891A/en
Application granted granted Critical
Publication of TWI367755B publication Critical patent/TWI367755B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A coated preparation of the film coat, which comprises the medicament with bad-smelling in the preparation, and contains carboxymethi cellulose sodium in the film coat.
TW095117776A 2005-05-20 2006-05-19 Film coated product TWI367755B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005147436 2005-05-20

Publications (2)

Publication Number Publication Date
TW200719891A true TW200719891A (en) 2007-06-01
TWI367755B TWI367755B (en) 2012-07-11

Family

ID=37431333

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095117776A TWI367755B (en) 2005-05-20 2006-05-19 Film coated product

Country Status (5)

Country Link
JP (1) JP5000491B2 (en)
KR (1) KR101318032B1 (en)
CN (1) CN101171006B (en)
TW (1) TWI367755B (en)
WO (1) WO2006123765A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5241503B2 (en) * 2006-10-25 2013-07-17 第一三共株式会社 Packaging material
BRPI0719395C1 (en) * 2006-12-07 2021-05-25 Daiichi Sankyo Co Ltd film coated tablet
TW200833325A (en) * 2006-12-26 2008-08-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising ascorbic acid
TWI414310B (en) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd Elution-improved pharmaceutical preparation
JPWO2009057569A1 (en) * 2007-10-29 2011-03-10 第一三共株式会社 Film coating formulation
JP5688799B2 (en) * 2008-08-11 2015-03-25 第一三共株式会社 Odor control method
JP5886530B2 (en) * 2010-02-26 2016-03-16 第一三共株式会社 tablet
SI2612681T1 (en) 2010-08-31 2019-05-31 Toray Industries, Inc. Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
CN102028663B (en) * 2010-12-14 2011-11-30 北京万生药业有限责任公司 Stable olmesartan medoxomil solid preparation
WO2012174731A1 (en) * 2011-06-24 2012-12-27 Cheng Haiyung Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
TWI461215B (en) * 2011-06-24 2014-11-21 Acenda Pharma Inc Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
WO2014188728A1 (en) * 2013-05-24 2014-11-27 持田製薬株式会社 Film-coating composition
JP6653116B2 (en) * 2014-08-27 2020-02-26 日本ケミファ株式会社 Olmesartan prodrug formulations
JP6360007B2 (en) * 2015-06-12 2018-07-18 富士フイルム株式会社 Method for producing drug-containing particles
JP6934859B2 (en) * 2016-03-24 2021-09-15 第一三共株式会社 Medicines for the treatment of kidney disease
KR102103530B1 (en) * 2018-06-29 2020-04-22 주식회사 코피텍 Composition for film-coating and tablet coated with the composition
CN114522146A (en) * 2022-01-21 2022-05-24 上海睿奕生物科技有限公司 White titanium-free film coating material and preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
CN1295469A (en) * 1998-12-31 2001-05-16 赫尔克里士公司 Hydroxypylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings
CN1740182A (en) * 1999-12-22 2006-03-01 症变治疗公司 Novel bisamidate phosphonate prodrugs
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
WO2002041890A1 (en) * 2000-11-21 2002-05-30 Sankyo Company, Limited Medicinal compositions
JP4107831B2 (en) * 2000-11-21 2008-06-25 第一三共株式会社 Pharmaceutical composition
JP4647851B2 (en) * 2001-08-07 2011-03-09 日立マクセル株式会社 The camera module
CA2514921C (en) * 2003-01-31 2013-04-30 Sankyo Company, Limited Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension
JP5248733B2 (en) * 2003-11-28 2013-07-31 エスエス製薬株式会社 Volatilization-preventing solid preparation and method for producing the same

Also Published As

Publication number Publication date
JPWO2006123765A1 (en) 2008-12-25
CN101171006A (en) 2008-04-30
JP5000491B2 (en) 2012-08-15
CN101171006B (en) 2010-12-01
WO2006123765A1 (en) 2006-11-23
TWI367755B (en) 2012-07-11
KR101318032B1 (en) 2013-10-14
KR20080011394A (en) 2008-02-04

Similar Documents

Publication Publication Date Title
TW200719891A (en) Film coated product
USD538660S1 (en) Container
USD595145S1 (en) Combined bottle and stopper
USD620228S1 (en) Singlet
USD597280S1 (en) Panty
USD603724S1 (en) Watch
GEP20115245B (en) Solid preparation
USD605950S1 (en) Bottle
CA118619S (en) Hinged container
USD932056S1 (en) Lite for doors and entryways
USD596030S1 (en) Container
TW200719888A (en) A film-coated drug product comprising dextrose
UA93903C2 (en) Tetrahydroisoquinoline derivatives to enhance memory function
EP2075295A4 (en) Coating solution and coated paper coated with the same
USD588827S1 (en) Sofa
CA118307S (en) Pasta dispenser disk
CA120191S (en) Absorbent sheet dispenser
BRPI0816507A2 (en) "EDIBLE PRODUCT, PROCESS FOR THE PREPARATION OF A COATED CAPSULE AND USE OF AN EDIBLE PRODUCT"
USD572431S1 (en) Pants
WO2007056607A3 (en) Denture adhesive article packaging
USD595146S1 (en) Combination bottle and stopper
CA114146S (en) Correction and glue tape dispenser
USD603093S1 (en) Cosmetic applicator
USD558459S1 (en) Mirror
CA120290S (en) Package for an ophthalmic product

Legal Events

Date Code Title Description
MC4A Revocation of granted patent